From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC)
Article in Diagnostics (December 2023)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer
Article in Molecular Biomedicine (December 2022)
Tackling Current Biomedical Challenges With Frontier Biofabrication and Organ-On-A-Chip Technologies
Article in Frontiers in Bioengineering and Biotechnology (September 2021)